Pamidronate for pain control in patients
β
B. ThΓΌrlimann; R. Morant; W. F. Jungi; A. Radziwill
π
Article
π
1994
π
Springer-Verlag
π
English
β 495 KB
In a prospective dose-escalation study tolerability and effectiveness of repeated infusions with intravenous pamidronate were investigated. A total of 80 patients with proven malignancy and pain due to osteolytic bone disease were enrolled. Doses of 30 mg, 45 mg, 60 mg and 90 mg pamidronate, given e